Found: 43
Select item for more details and to access through your institution.
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Potentially inappropriate medication use in older patients with breast and colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The biology of ovarian cancer: new opportunities for translation.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Physiologic and Pathologic Drug Resistance in Ovarian Carcinoma: A Hypothesis Based on a Clonal Progression Model.
- Published in:
- Acta Oncologica, 1998, v. 37, n. 7/8, p. 629, doi. 10.1080/028418698429964
- By:
- Publication type:
- Article
Physiologic and Pathologic Drug Resistance in Ovarian Carcinoma: A Hypothesis Based on a Clonal Progression Model.
- Published in:
- Acta Oncologica, 1998, v. 37, n. 7/8, p. 629, doi. 10.1080/028418698429964
- By:
- Publication type:
- Article
Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041170
- By:
- Publication type:
- Article
CA125/MUC16 Is Dispensable for Mouse Development and Reproduction.
- Published in:
- PLoS ONE, 2009, v. 4, n. 3, p. 1, doi. 10.1371/journal.pone.0004675
- By:
- Publication type:
- Article
A Bayesian Approach to Dose-Response Assessment and Synergy and Its Application to In Vitro Dose-Response Studies.
- Published in:
- Biometrics, 2010, v. 66, n. 4, p. 1275, doi. 10.1111/j.1541-0420.2010.01403.x
- By:
- Publication type:
- Article
Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2850-8
- By:
- Publication type:
- Article
The Emerging Role of HE4 in the Evaluation of Epithelial Ovarian and Endometrial Carcinomas.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 6, p. 1
- By:
- Publication type:
- Article
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
- Published in:
- 2001
- By:
- Publication type:
- commentary
Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.
- Published in:
- Oncogene, 2005, v. 24, n. 40, p. 6174, doi. 10.1038/sj.onc.1208753
- By:
- Publication type:
- Article
Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C α activity.
- Published in:
- Oncogene, 2001, v. 20, n. 57, p. 8258, doi. 10.1038/sj.onc.1205039
- By:
- Publication type:
- Article
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133077
- By:
- Publication type:
- Article
OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1519, doi. 10.3390/cancers13071519
- By:
- Publication type:
- Article
A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 913, doi. 10.3390/cancers13040913
- By:
- Publication type:
- Article
A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 446, doi. 10.3390/cancers13030446
- By:
- Publication type:
- Article
Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 485, doi. 10.3390/cancers12020485
- By:
- Publication type:
- Article
Current Challenges and Future Directions in the Management of Ovarian Cancer: Proceedings of the First Global Workshop on Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2010, v. 3, n. 2, p. 81, doi. 10.3816/COC.2010.n.015
- By:
- Publication type:
- Article
ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins.
- Published in:
- Bioscience Reports, 2010, v. 30, n. 3, p. 159, doi. 10.1042/BSR20090008
- By:
- Publication type:
- Article
SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 13, p. 2558, doi. 10.1002/1878-0261.13208
- By:
- Publication type:
- Article
Expression of p16 induces transcriptional downregulation of the RB gene.
- Published in:
- Oncogene, 1998, v. 16, n. 1, p. 1, doi. 10.1038/sj.onc.1201525
- By:
- Publication type:
- Article
Imprinted Tumor Suppressor Genes ARHI and PEG3 Are the Most Frequently Down-regulated in Human Ovarian Cancers by Loss of Heterozygosity and Promoter Methylation.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 7, p. 1489, doi. 10.1002/cncr.23323
- By:
- Publication type:
- Article
Conquering Cancer in Our Lifetime: New Diagnostic and Therapeutic Trends.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 1, p. 1, doi. 10.1373/clinchem.2012.186940
- By:
- Publication type:
- Article
Early detection of ovarian cancer.
- Published in:
- Disease Markers, 2007, v. 23, n. 5-6, p. 397
- By:
- Publication type:
- Article
Phase 2 study of canfosfamide in combinationwith pegylated liposomal doxorubicin in platinumand paclitaxel refractory or resistant epithelialovarian cancer.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Reproducibility of SELDI Spectra Across Time and Laboratories.
- Published in:
- Cancer Informatics, 2011, n. 9, p. 45, doi. 10.4137/CIN.S6438
- By:
- Publication type:
- Article
Reproducibility of SELDI Spectra Across Time and Laboratories.
- Published in:
- Cancer Informatics, 2011, n. 10, p. 45, doi. 10.4137/CIN.S6438
- By:
- Publication type:
- Article
The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 8, p. 1661, doi. 10.1002/cncr.25701
- By:
- Publication type:
- Article
Dasatinib Induces Autophagic Cell Death in Human Ovarian Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 21, p. 4980, doi. 10.1002/cncr.25426
- By:
- Publication type:
- Article
CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
CA 125 and the Detection of Recurrent Ovarian Cancer.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
MEKK3 Expression Correlates With Nuclear Factor κ B Activity and With Expression of Antiapoptotic Genes in Serous Ovarian Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 17, p. 3897, doi. 10.1002/cncr.24445
- By:
- Publication type:
- Article
Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2012, v. 10, n. 2, p. 155
- By:
- Publication type:
- Article
IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03420-0
- By:
- Publication type:
- Article
Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 243, doi. 10.1186/1471-2407-12-243
- By:
- Publication type:
- Article
Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 1, doi. 10.1186/1471-2407-11-22
- By:
- Publication type:
- Article
Tumor suppressor genes are frequentlymethylated in lymph node metastases of breastcancers.
- Published in:
- BMC Cancer, 2010, v. 10, p. 378, doi. 10.1186/1471-2407-10-378
- By:
- Publication type:
- Article